Joshua Y C Yang

Suggest Changes
  • Citations Per Year
Learn More
Belatacept use has been constrained by higher rates of acute rejection. We hypothesized that belatacept with low-dose rATG and initial mycophenolate maintenance with conversion to everolimus at 1(More)
  • 1